Darunavir | List of Frontiers open access articles

Original Research

Published on 10 Apr 2015

Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter

in Drug Metabolism and Transport

Darren M. Moss
Neill J. Liptrott
Marco Siccardi
Andrew Owen

Frontiers in Pharmacology

doi 10.3389/fphar.2015.00078

6,273 views
20 citations

Original Research

Published on 03 Feb 2016

Unique Flap Conformation in an HIV-1 Protease with High-Level Darunavir Resistance

in Virology

Masaaki Nakashima
Hirotaka Ode
Koji Suzuki
Masayuki Fujino
Masami Maejima
Yuki Kimura
Takashi Masaoka
Junko Hattori
Masakazu Matsuda
Atsuko Hachiya

Frontiers in Microbiology

doi 10.3389/fmicb.2016.00061

6,123 views
16 citations

Systematic Review

Published on 01 Nov 2021

HIV Protease Inhibitors and Insulin Sensitivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

in Drugs Outcomes Research and Policies

Violet Dismas Kajogoo
Mary Gorret Atim
Demeke Amare
Melka Geleta
Yilkal Muchie
Hanna Amanuel Tesfahunei
Willyhelmina Olomi
Joan Acam
Tsegahun Manyazewal

Frontiers in Pharmacology

doi 10.3389/fphar.2021.635089

6,516 views
21 citations

Original Research

Published on 15 Aug 2022

The structural, dynamic, and thermodynamic basis of darunavir resistance of a heavily mutated HIV-1 protease using molecular dynamics simulation

in Biological Modeling and Simulation

Yaser Shabanpour
Sharareh Sajjadi
Esmaeil Behmard
Parviz Abdolmaleki
Amir Homayoun Keihan

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2022.927373

3,794 views
7 citations

Original Research

Published on 16 Jan 2025

Comparative efficacy of repurposed drugs lopinavir-ritonavir and darunavir-ritonavir in hospitalised COVID-19 patients: insights from a tertiary centre cohort

in Clinical and Diagnostic Microbiology and Immunology

Dóra Paróczai
András Bikov
Andreea Blidaru
Emanuel Bobu
Ana Lascu
Cristian Ion Mot
Stefan Mihaicuta
Stefan Frent

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1496176

2,289 views

Original Research

Published on 19 Mar 2018

Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study

in HIV and AIDS

Olivier Ségéral
Eric Nerrienet
Sansothy Neth
Bruno Spire
Vohith Khol
Laurent Ferradini
Saramony Sarun
Chandara Mom
Sopheak Ngin
Charlotte Charpentier

Frontiers in Public Health

doi 10.3389/fpubh.2018.00063

6,428 views
8 citations

Articles

Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter

Unique Flap Conformation in an HIV-1 Protease with High-Level Darunavir Resistance

HIV Protease Inhibitors and Insulin Sensitivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

The structural, dynamic, and thermodynamic basis of darunavir resistance of a heavily mutated HIV-1 protease using molecular dynamics simulation

Comparative efficacy of repurposed drugs lopinavir-ritonavir and darunavir-ritonavir in hospitalised COVID-19 patients: insights from a tertiary centre cohort

Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study